Among the causes, modifications of the mitochondrial function could be of major importance. Polyunsaturated fatty (-3) acids have been shown to play a role in intracellular functions. We hypothesize that docosahexaenoic acid (DHA) supplementation could improve muscle mitochondrial function that could contribute to limit the early consequences of aging on adult muscle. Twelve-month-old male Wistar rats were fed a low-polyunsaturated fat diet and were given DHA (DHA group) or placebo (control group) for 9 wk. Rats from the DHA group showed a higher endurance capacity (ϩ56%, P Ͻ 0.05) compared with control animals. Permeabilized myofibers from soleus muscle showed higher O2 consumptions (P Ͻ 0.05) in the DHA group compared with the control group, with glutamate-malate as substrates, both in basal conditions (i.e., state 2) and under maximal conditions (i.e., state 3, using ADP), along with a higher apparent Km for ADP (P Ͻ 0.05). Calcium retention capacity of isolated mitochondria was lower in DHA group compared with the control group (P Ͻ 0.05). Phospho-AMPK/AMPK ratio and PPAR␦ mRNA content were higher in the DHA group compared with the control group (P Ͻ 0.05). Results showed that DHA enhanced endurance capacity in adult animals, a beneficial effect potentially resulting from improvement in mitochondrial function, as suggested by our results on permeabilized fibers. DHA supplementation could be of potential interest for the muscle function in adults and for fighting the decline in exercise tolerance with age that could imply energy-sensing pathway, as suggested by changes in phospho-AMPK/AMPK ratio. polyunsaturated fatty acids; isolated mitochondria; permeabilized myofibers; muscle bioenergetics AGING IS ASSOCIATED WITH A PROGRESSIVE DECREASE in muscle mass and alterations in muscle function leading to reduced physical abilities, exercise performance and quality of life, and ultimately disabilities (21, 26, 36) . Among the causes of such sarcopenia, inadequate protein synthesis matching protein degradations is of major importance (4, 12). Also, changes in metabolism could be part of the muscle mass decrease with age.
AGING IS ASSOCIATED WITH A PROGRESSIVE DECREASE in muscle mass and alterations in muscle function leading to reduced physical abilities, exercise performance and quality of life, and ultimately disabilities (21, 26, 36) . Among the causes of such sarcopenia, inadequate protein synthesis matching protein degradations is of major importance (4, 12) . Also, changes in metabolism could be part of the muscle mass decrease with age. It has already been reported that muscle mitochondrial changes occur with age. Oxidative enzyme activities have been shown to be reduced with age (52) . In rodents, the electron transport chain also appears affected since the number of cytochrome oxidase-deficient/succinate dehydrogenase-hyperreactive (COX Ϫ /SDH ϩϩ ) muscle fibers increases (8) . In a previous study, we showed that aged muscle fibers display several functional abnormalities, including higher mitochondrial reactive oxygen species (ROS) production and lower state 3 respiration rate with pyruvate as a substrate (39) . These changes could contribute to the imbalance between protein synthesis and degradation and vulnerability to apoptosis exhibited by sarcopenic muscle (9, 23, 40) . They appear to be related to modifications of the fatty acid profile of mitochondrial lipids (39) .
Several strategies can be considered to prevent such progressive muscle loss with age. Some studies suggest that dietary n-3 polyunsaturated fatty acids could be beneficial to limit loss of skeletal muscle mass (55) . These compounds could act by either activation of anabolic signaling pathways or through their anti-inflammatory properties (17, 22, 53) . They could also have positive impacts through changes in metabolism. Among n-3 polyunsaturated fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) show the most interesting properties (18) . Their effects have been studied on cardiac and skeletal muscles, but with limited focus on mitochondrial function. It has been reported that n-3 polyunsaturated fatty acids increase cardiac mitochondrial calcium retention capacity without any change in oxygen consumption (32, 45) . However, the combination of DHA and EPA and the use of marine oil have been reported to have less profound effect compared with DHA alone (33) . Additionally, DHA ϩ EPA supplementation has significant effects on skeletal muscle mitochondrial ADP sensitivity (28) , but its role in the improved exercise capacity in patients has not been yet addressed (7) . Surprisingly, little is known about DHA supplementation in adult skeletal muscle before the aging-related decline of skeletal muscle mass and function starts and accelerates. We hypothesized that due to its higher ability to change membrane lipid composition and its effects on mitochondrial function reported elsewhere, DHA supplementation could improve skeletal muscle function, leading to a higher exercise capacity through a better oxidative metabolism. The aim of the present study was to assess the effects of a DHA supplementation before early age-related alterations of the endurance exercise capacity and the mitochondrial function of oxidative skeletal muscle fibers in adult rats. Mitochondrial function was studied using two approaches: permeabilized fibers allowing the study of mitochondria in their cellular environment and isolated mitochondria allowing precise location of the putative changes on the respiratory chain. Unlike most studies designed to determine the effects of DHA on muscle in young rats, we used adult animals to explore such nutritional supplementation on the early times of muscle aging when no significant muscle mass loss is yet noticeable (59) .
MATERIALS AND METHODS

Materials.
Reagents were purchased with the highest quality available from Sigma-Aldrich, unless otherwise stated. DHA supplement was from Applications Santé des Lipides (Vichy, France). DHAenriched egg phospholipids containing 8.34% (wt/wt) of DHA were prepared from eggs produced by laying hens fed a fish oil-supplemented diet. Egg phospholipids contained by weight 75% phosphatidylcholine, 20% phosphatidylethanolamine, 2% triacylglycerides, and 0.3% cholesterol. Ninety-nine percent of the DHA was associated with the phospholipids. This form is reported to be more stable than triglycerides-DHA toward peroxidation (56) . The supplementation was given by oral gavage in the form of preswollen phospholipids (40% by weight in water) prepared freshly every day and kept at 4°C until use.
Animals. Male Wistar rats (Charles River Laboratories) aged 10 -12 mo were used in this study. They were housed in a thermoneutral environment (22 Ϯ 2°C) on a 12:12-h light-dark cycle. The experiments followed the French Ministry of Agriculture and the European Union recommendations, in conformity with the Public Health Service Policy on Humane Care and Use of Laboratory Animals, and were approved by the Board of the Animal Facility of the Department of Biology of the Université Joseph Fourier (M. Le Guen, V. Chaté, and H. Dubouchaud hold individual licenses to experiment on living animals issued by the Veterinary Services Department of the French Ministry of Agriculture). Animals were fed with a low -3 diet to reproduce the low--3 diet that is now common in Western countries, with the objective to decrease the -6/-3 ratio (UPAE Jouy-en-Josas, France; Table 1 ) ad libitum with free access to drinking water. For 9 wk, they were given a daily oral dose of DHA phospholipid-enriched supplementation (90 mg·kg body wt Ϫ1 ·day Ϫ1 , corresponding to an intake of DHA phospholipids of ϳ12-15 mg/kg body wt; DHA group) or placebo without DHA (control group).
Endurance exercise test. All animals were familiarized with a motorized rodent treadmill, using running sessions for 1 wk, 5 min/day. After familiarization, rats performed a treadmill running (10% positive grade at 20 m/min) until exhaustion, which was defined as the first occurrence of failing to keep up with the treadmill speed for a period of 1 min despite mild electrical shock stimulation to maintain the running motivation.
Indirect calorimetry. Oxygen consumption (V O2), carbon dioxide production (V CO2), and respiratory exchange ratio (RER) were monitored using an indirect open-circuit calorimeter in individual cages over 2 days during the last week of the protocol (LE 405; PanlabBioseb). Airflow rate was obtained from a gas pump and a flow meter (Panlab-Bioseb). Data from the 2nd day were recorded using a computer-assisted data acquisition program (Metabolism Calculation Software Version 2.0.2). Energy expenditure (EE) was calculated according to the following formula provided by the supplier and expressed in kcal·day Ϫ1 ·g body wt 0.75 : EE ϭ (3.815 ϩ 1.232 ϫ V O2/V CO2) ϫ V O2 ϫ 1.44.
Blood and tissue sampling. At least 48 h after the end of the running test, rats were deeply anesthetized by an intraperitoneal injection of pentobarbital sodium (5 mg/100 g body wt) to ensure blood and tissue sampling, followed by euthanasia by heart excision. Blood samples were centrifuged to separate plasma and packed red blood cells before storage at Ϫ80°C until further analysis. Retroperitoneal and mesenteric adipose tissues were collected and weighed. Soleus, plantaris, and red portions of vastus muscles were dissected out. Parts were frozen in liquid nitrogen and stored at Ϫ80°C. Remaining parts were used to prepare permeabilized myofibers or isolated mitochondria, as described below.
Fatty acid composition of cell membrane phospholipids. The phospholipid fatty acid composition was determined in red blood cells and in plantaris muscle homogenates, as described previously (61) . The lipids were extracted according to the method of Folch et al. (19) . The phospholipids were separated from nonphosphorus lipids using a Sep-pack cartridge (30) . After transmethylation, the fatty acid methyl esters were separated and analyzed by gas chromatography.
Biochemical assays
Triglycerides and total cholesterol concentrations were measured in plasma using kits from Roche Diagnostics (Meylan, France) on a Hitachi 912 automatic analyzer. Protein oxidation in the plasma was evaluated by the disappearance of protein thiol groups (16) . Standards and plasma samples (20 l) were measured spectrophotometrically at 415 nm in 50 mM phosphate buffer, 100 mM EDTA, pH 8, and 10 mM bis-5,5=-dithio-bis(2-nitrobenzoic acid). The antioxidant status of the plasma was evaluated using ferric-reducing antioxidant power (FRAP) assay as a global marker of the antioxidant power (5). The FRAP assay uses antioxidants as reductants in a redox-linked colorimetric method. In this assay, at low pH, a ferrictripyridyltriazine (FeIII-TPTZ) complex is reduced to the ferrous form, which is blue and monitored by measuring the change in absorbance at 593 nm. The change in absorbance is directly proportional to the reducing power of the electron-donating antioxidants present in plasma. The absorbance change is translated into a FRAP value (in mol/l) by relating the change of absorbance at 593 nm of test sample to that of a standard solution of known FRAP value. Lipid peroxidation was assessed by measuring the concentration of thiobarbituric acid-reactive substances (TBARS) in plasma (15) . TBARS were determined in soleus muscle homogenates using the fluorimetric determination of malondialdehyde-thiobarbituric acid complexes after acid hydrolysis. Briefly, homogenate aliquots were mixed with 7% thiobarbituric acid-perchloric acid (2:1, vol/vol) and incubated at 95°C. After cooling, n-butanol was added for the extraction, and then the aliquots were centrifuged for 10 min at 3,500 g. Fluorescence was determined in the supernatant at excitation and emission wavelengths of 532 and 553 nm, respectively. Fluorescence was compared with a standard curve obtained from a solution of 1,1,3,3-tetraethoxypropane, with known concentrations ranging from 0 to 8 mol/l.
Myofiber isolation and permeabilization. Permeabilized skeletal muscle fibers were prepared from soleus muscle using a method described earlier (35 Mitochondria isolation. Mitochondria were isolated from red portions of vastus muscles chopped in an ice-cold isolation medium (150 mM sucrose, 75 mM KCl, 1 mM KH2PO4, 5 mM MgCl2, 1 mM EGTA, and 50 mM Tris·HCl, pH 7.4). Muscle pieces were transferred into 30 ml of isolation buffer supplemented with 0.2% fat-free bovine serum albumin and 0.2 mg/ml subtilisin. After a 1-min incubation, the suspension was diluted twice with isolation medium and homogenized using a motor-driven glass-teflon pestle homogenizer. Nuclei and cell debris were removed by centrifugation at 800 g for 10 min at 4°C. Mitochondria were isolated from the supernatant by spinning twice at 8,000 g for 10 min at 4°C. The mitochondrial pellet was resuspended in 0.5 ml of isolation buffer and kept on ice. Mitochondrial protein contents were determined using the bicinchoninic acid assay (Pierce), with BSA as a standard.
Oxygen consumption measurement. Rates of oxygen consumption by permeabilized myofibers and isolated mitochondria were measured using a Clark-type O2 electrode (Oxygraph; Hansatech Instruments). Mitochondria (0.2 mg/ml) were incubated at 30°C in a respiration buffer containing 125 mM KCl, 5 mM Pi, 20 mM Tris·HCl, 0.1 mM EGTA, and 0.1% fat-free BSA (pH 7.2). The suspension was stirred constantly with a built-in electromagnetic stirrer and bar flea. Mitochondria were energized with the various substrates glutamate-malate (GM; 5 mM/2.5 mM) or succinate (S; 5 mM), either alone or in combination (GMS), or octanoyl-carnitine (110 M), and oxygen consumption was recorded before and after 1 mM ADP was added and following the addition of oligomycin (1.25 g/ml). When succinate was used alone, rotenone was added in the respiratory chamber. Fiber bundles (ϳ0.60 mg dry wt) were incubated in 1 ml of solution B at 25°C with continuous stirring. Two types of protocols were applied. First, basal oxygen consumption of permeabilized myofibers (V0) due to proton leak was measured without any substrate. After addition of the various substrates GM (5:2.5 mM) or S (5 mM) either alone or in combination; GMS), maximal oxygen consumption rate (Vmax) was measured under ADP stimulation (1 mM). During the second protocol, following measurement of V0 and then addition of GMS, respiration rate was accelerated by the addition of successive amounts of ADP until it reached the maximal oxygen consumption. Apparent Km for ADP (apparent Km for ADP) was calculated using a nonlinear fitting of the Michaelis-Menten modeling equation. After every measurement, fiber bundles were carefully removed, dried overnight at room temperature, and then heated at 100°C for 10 min and weighed. Myofiber respiration rates were expressed as nmol O·min Ϫ1 ·mg dry wt Ϫ1 , and mitochondrial respiration rates were expressed as nmol O·min Ϫ1 ·mg protein Ϫ1 . Mitochondrial H 2O2 release. Generation of mitochondrial H2O2 was determined by fluorimetry by measuring the linear increase in fluorescence due to enzymatic oxidation of amplex red (excitation at 312 nm, emission at 420 nm) by H2O2 in the presence of horseradish peroxidase (37) . Muscle mitochondria (0.2 mg/ml) were incubated at 30°C in the same medium as for mitochondrial respiration added with 6 U.mL Ϫ1 (for consistency with other concentrations) of horseradish peroxidase and 1 M amplex red. The reaction was started by addition of the same substrates used for mitochondrial respiration: GM (5:2.5 mM) or S [5 mM either alone or in combination (GMS)] or octanoylcarnitine (110 M). Mitochondrial H2O2 release was measured both in basal conditions (substrate alone) and after sequential addition of 2 mM rotenone and 2 mM antimycin A to determine the maximum rate of H2O2 production of complexes I and I ϩ III of the respiratory chain, respectively.
Calcium retention capacity. Sensitivity of the permeability transition pore (PTP) was evaluated by determining calcium retention capacity of mitochondria (50 g) incubated at 30°C in 250 mM saccharose, 10 mM Tris-MOPS, 1 mM P i-Tris, and 0.25 M calcium green-5N (excitation at 505 nm, emission at 535 nm), pH 7.4. Respiratory substrates were GM or S as for respiration measurements. Pulses of 10 nmol of Ca 2ϩ were added every minute. Calcium retention capacity (CRC) is defined as the amount of Ca 2ϩ accumulated by mitochondria prior to the Ca 2ϩ pulse that induces pore opening and Ca 2ϩ release. Specificity of mitochondrial pore opening was further assessed by measuring CRC in the presence of 1 M cyclosporin A (CsA) as the reference inhibitor of PTP opening (44) .
Respiratory chain complexes, citrate synthase, and 3-hydroxyacylCoA dehydrogenase activities. Soleus samples (50 mg) were homogenized at 4°C in 450 l of 100 mM KH 2PO4, pH 7.4. The homogenates were centrifuged (1,500 g, 5 min, 4°C), and the resulting supernatant was collected and stored at Ϫ80°C until determination of the various enzymatic activities. Activities of the NADH-ubiquinone oxidoreductase (complex I), succinate-ubiquinone oxidoreductase (complex II), ubiquinol cytochrome c reductase (complex III), and cytochrome c oxidase (complex IV) were determined as described previously (42) . Enzymatic activities were expressed as mol·min Ϫ1 ·mg protein
Ϫ1
. Activity of citrate synthase was assessed according to Srere (57) on soleus homogenates (100 times diluted) at 37°C. Results were expressed as mol·min Ϫ1 ·mg Ϫ1 of tissue. Activity of the 3-hydroxyacyl-CoA dehydrogenase (HAD) was quantified by measuring the decrease in absorbance at 340 nm resulting from the oxidation of NADH and the reduction of S-acetoacetyl-CoA. The measurement was performed in 200 mol/l NADH, 60 mol/l EDTA, and 40 mmol/l imidazole, pH 7. After initial measurement (nonspecific activity), 50 mol/l Sacetoacetyl-CoA was added to determine the specific activity expressed in nmol·min Ϫ1 ·g protein Ϫ1 . Western blot analysis. Soleus muscle portions (10 -30 mg) were homogenized (1:50) in 20 mM HEPES, 2 mM EGTA, 50 mM ␤-glycerophosphate, 3 mM benzamidine, 10% glycerol, 1% Triton X-100, 1 mM dithiothreitol, and 0.2 mM Na3VO4 supplemented with anti-protease cocktail (cOmplete protease inhibitor, 1 tablet/10 ml; Roche). Samples were centrifuged at 200 g for 10 min at 4°C, and supernatant protein concentration was determined as described earlier.
Protein extracts (50 g) were subjected to SDS-PAGE with a 15% acrylamide/bis-acrylamide gel for 1 h with 100 V constant current. Separated proteins were transferred on polyvinylidene fluoride membrane using a semi-dry system (Bio-Rad). Membranes were saturated by incubation in 5% nonfat dry milk in TBS-Tween 20 for 2 h at room temperature. Membranes were incubated under agitation with antibodies against total or phosphorylated (Thr 172 ) forms of AMPK, total or phosphorylated (Ser 2448 ) forms of mammalian target of rapamycin (mTOR), or phosphorylated (Ser/Thr) AMPK substrate (respective catalogue nos. 2532, 2535, 2972, 2971, and 5759; Cell Signaling Technology) overnight at 4°C and then washed in TBS-Tween 20 (3 times for 10 min). After incubation with appropriate secondary antibodies, reactions were revealed using enhanced chemiluminescence, and signals were acquired on a GE Healthcare imaging system. Band intensities were quantified using ImageJ software in arbitrary units and phosphorylated AMPK/total AMPK and phosphorylated mTOR/ total mTOR ratios were calculated and compared between groups.
Tissue mRNA expression. Total RNAs were extracted from frozen soleus muscle samples (20 mg) using the TriZol reagent method (Invitrogen). Concentration and purity of total RNA were verified by measuring optimal density at 260 and 280 nm. Integrity was checked by 1% agarose gel electrophoresis. To eliminate genomic DNA contamination, 1 g of total RNA was incubated with DNase amplification grade (Invitrogen). Immediately after DNA digestion, samples were reverse transcribed using 100 U of Moloney murine leukemia virus reverse transcriptase in a final volume of 20 l according to the manufacturer's instructions (Superscript III; Invitrogen), using oligo(dT)s as primers. Relative mRNA expression was determined by real-time PCR on a LightCycler (Roche Applied Science, Manheim, Germany) using the FastStart DNA Master SYBR Green I procedure. Efficiency of amplification was verified for each set of primers on a serial dilution of a pool of cDNA samples. Quantification of PCR products was done using the 2 Ϫ⌬⌬CT method with the LightCycler software 3.5, using the second derivative maximum method with acidic ribosomal phosphoprotein P0 as housekeeping gene. Primer sequences are reported in Table 2 .
Statistical procedures. All data are presented as means Ϯ SE. Student's t-test was used to determine the global effect of treatment. Statistical significance was accepted at P Ͻ 0.05. Rank sum tests were applied when values were nonnormally distributed.
RESULTS
Anthropometric and metabolic characteristics, exercise capacity, and plasma indices.
The supplementation with DHA had no effect on the final body weight of the animals (Table 3) . However, animals from both groups (control and DHA) showed a decrease in their body weight between the beginning (initial body weight) and the end (final body weight) of the study. These decreases are associated with a change in body composition in the DHA group, where mesenteric and retroperitoneal adipose tissue weights were smaller compared with the control group (Ϫ38 and Ϫ35%, respectively, P Ͻ 0.05). Control and DHA animals had the same food intake per day during the protocol, and indirect calorimetry measurement shows that there is no difference in the total energy expenditure or in the 24-h respiratory exchange ratio (Table 3) . DHA supplementation has no effects on the plasma oxidative parameters such as the FRAP, TBARS content, or the thiols groups content, although there is a tendency to increase in the DHA group (P ϭ 0.056) for the latter. As shown in Table 3 , animals supplemented with DHA had a greater exercise capacity, with an endurance time to exhaustion 1.5-fold that of control animals (31.3 Ϯ 3.1 vs. 20.5 min Ϯ 3.4, respectively, P Ͻ 0.05).
Effect of a DHA supplementation on erythrocyte and muscle cell membrane fatty acid compositions. Analysis of fatty acid composition revealed that DHA supplementation markedly altered the composition of membrane phospholipids (Table 4) . In red blood cell membrane, DHA supplementation was associated with larger proportions of n-3 fatty acids in the DHA group compared with control group, including EPA (C20:5 n-3), DHA (C22:6 n-3), and docosapentaenoic acid (C22:5 n-3). On the contrary, we measured lower ␥-linoenic acid (C18:3 n-3), docosapentaenoic acid (C22:5 n-6), and docosatetraenoic acid (C22:4 n-6) proportions. Total n-3 fatty acid proportion in red blood cell membranes was significantly higher in the DHA group compared with control group (3.89 Ϯ 0.25 vs. 2.00 Ϯ 0.21%, P Ͻ 0.05) and n-6/n-3 ratio was significantly lower (9.64 Ϯ 0.90 vs. 19.52 Ϯ 1.76). In muscle, phospholipid analysis revealed that the total n-6 fatty acid content was significantly lower in the DHA group compared with the control group (28.70 Ϯ 0.79 vs. 34.54 Ϯ 0.66%) along with the n-6/n-3 ratio (3.38 Ϯ 0.18 vs. 4.68 Ϯ 0.34%). Among unsaturated fatty acids, we noticed that DHA supplementation was associated with an increase in palmitoleic acid (C16:1 n-7) and in EPA (Table 4) . Surprisingly, total n-3 fatty acid content was not significantly increased with DHA supplementation, although it showed a tendency to be higher in the DHA group compared with the control group (Table 4) .
Mitochondrial enzyme activities and expression, respiration, and H 2 O 2 release. The activities of the four complexes of the mitochondrial respiratory chain were determined in whole soleus homogenates as well as the citrate synthase and HAD activities (Table 5 ). Both complex III and complex IV activities were higher in soleus from the DHA group compared with the control group (ϩ166 and ϩ57%, respectively, P Ͻ 0.05). There were no changes in citrate synthase, complex I, or complex II activities and a tendency toward a higher HAD activity in DHA compared with control (P ϭ 0.1). The contents of the respiratory complexes evaluated by Western blotting were also similar in both groups (Fig. 1) . The oxygen consumption was measured on isolated mitochondria Arbp, acidic ribosomal phosphoprotein P0 (ARBP); adipoq, adiponectin (Adipoq); hadh, hydroxyacyl-CoA dehydrogenase (HAD); trim63, muscle RING finger protein-1 (MuRF1); rela, nuclear factor-B subunit p65 (NF-B) ; ppargc1a, peroxisome proliferator-activated recepto-␥ coactivator-1␣ (PGC-1␣) ; ppard, peroxisome proliferator-activated receptor-␦ (PPAR␦). Data are means Ϯ SE; n Ն 8, except for the thiols groups and ferric ion-reducing antioxidant parameter (FRAP), where n Ն 5. RER, mean respiratory exchange ratio over 24 h; TBARS, thiobarbituric acid-reactive substances; EE, energy expenditure. *Different from control, P Ͻ 0.05; #different from initial, P Ͻ 0.05. prepared from red portions of vastus muscle (Table 6 ). Using this approach, state 2 (nonphosphorylating) and state 3 (ADP stimulated) oxygen consumption were similar in isolated mitochondria from the DHA and control groups, whatever the substrate used to energize the electron transport chain ( Table  6 ). Release of H 2 O 2 from isolated mitochondria was measured in the basal condition (substrate alone), after inhibition of complex I (by addition of rotenone), and after final inhibition of complex III (by addition of antimycin A). There were no differences in H 2 O 2 release between groups independently of the substrate used (Table 7) . We observed higher H 2 O 2 releases with GMS or S as substrate compared with GM or octanoyl-C in both groups. Rotenone exerted an inhibitory effect on the H 2 O 2 release when complex II substrates were used (GMS or S), and antimycin A addition revealed higher H 2 O 2 releases from isolated mitochondria in similar proportions in the DHA and control groups, whatever the substrate (Table 7) .
Respiration was also measured on permeabilized myofibers from soleus (oxidative) muscle (Fig. 2) . Oxygen consumption by soleus muscle permeabilized myofibers was higher in the DHA group compared with the control group in the basal condition (substrate alone) with GM ( Fig. 2A) or S (Fig. 2B) as substrate but not in combination (GMS; Fig.  2C ). Activation of respiration with ADP increased the oxygen consumption, but only the GM condition showed a higher oxygen consumption in the DHA group compared with control group (6.31 Ϯ 0.22 vs. 4.44 Ϯ 0.26 nmol O·min Ϫ1 ·mg dry wt Ϫ1 , respectively, P Ͻ 0.05). Permeabilized myofiber respiration measured with increasing ADP concentrations allowed the calculation of the apparent K m values for ADP (Fig. 3) . Results show that, in soleus, affinity for ADP was lower as judged by a higher apparent K m for ADP in the DHA group compared with control group was 73 Ϯ 6 vs. 335 Ϯ 27 M, respectively (P Ͻ 0.05).
Calcium retention capacity. Mitochondrial permeability transition pore opening was determined with two different substrates (GM and S) on isolated mitochondria, and results are presented on Fig. 4 . DHA supplementation for 9 wk induced a significantly lower CRC with substrates alone (Ϫ34% with GM and Ϫ26% with S). This effect was also observed in the presence of CsA, but only with GM as a substrate (Fig. 4) . The inhibitory effect of CsA on the PTP opening was seen on isolated mitochondria from the DHA group only, as CRC in the presence of CsA was higher compared with CRC with substrates alone (ϩ31 vs. ϩ52%, respectively, P Ͻ 0.05). CsA had a tendency to inhibit the PTP opening in the control group.
AMPK content and activity. We found that DHA supplementation significantly stimulated the phosphorylation of AMPK on Thr 172 in soleus muscle (Fig. 5A) . However, content of total AMPK seemed to be unaffected by a 9-wk DHA supplementation. As a result, the phosphorylated (p)-AMPK/AMPK ratio was found to be 2.19 Ϯ 0.29 higher in the DHA group compared with the control group (P Ͻ 0.05; Fig. 5B ), which was associated with a tendency toward a higher phosphorylation level of mTOR, one of its putative targets, in the DHA group compared with the control group (P ϭ 0.06; Fig. 6 ). This increase was associated with a higher level of p-(Ser/Thr) AMPK substrates, as suggested in Fig. 7 , where lanes from the DHA group were of higher densities compared with that of the control group (ϩ35%, P Ͻ 0.05).
Tissue mRNA expression. Relative expression of adiponectin, HAD, muscle RING finger protein-1, NF-B, and peroxisome proliferator-activated receptor (PPAR)␥ were similar in both the control and DHA groups, whereas PPAR␥ coactivator-1␣ tended to be higher (P ϭ 0.07) in the DHA group compared with the control group (Fig. 8) . However, PPAR␦ mRNA was found to be higher in the DHA group compared with the control group (P Ͻ 0.05; Fig. 8 ).
DISCUSSION
The main findings of the study are that a 9-wk supplementation with phospholipids of DHA significantly enhances the endurance exercise capacity of middle-aged male rats in association with significant changes in the mitochondrial function at the skeletal muscle level. Our goal was to study the effect of DHA on muscle function and metabolism before any significant changes due to aging occurred. For that purpose, and unlike most of the studies, we used middle-aged (12 mo old) male rats. It has been reported that deficiency in unsaturated fatty acids is related to decline in skeletal muscle performance (54) . Studies on the evolution of Western diet during the last century show that linoleic acid intake increases, leading to a decrease in tissue DHA contents (6) . Therefore, to mimic such a modification in our animals, we fed them with a low-unsaturated fat diet during the entire study, as commercial standard diets usually contain unsaturated fat blends. Moreover, DHA supplementation has a significant effect on body composition, as we observed a significant decrease in the weight of both mesenteric and retroperitoneal adipose tissues. Such a decrease cannot be attributed to a lower food intake, as this parameter was similar in both groups. Fish oil consumption has been reported to enhance fat oxidation in humans (11) . Therefore, we can hypothesize that, in our study, DHA could have the same effect, although we only have a tendency toward a decrease in RER with DHA but maybe still sufficient to have significant changes in body fat content.
We administered phospholipids of DHA instead of the more classic triglyceride form, as it has been reported that phospholipids of DHA are more resistant to oxidation and thus display a better bioavailability with significant incorporation in cell membranes (56) . We confirm here that DHA supplementation modifies lipid composition of red blood cell membrane as well as skeletal muscle cell, as reported elsewhere (2, 3) . Among significant alterations, we can notice that DHA induced a decrease in the n-6/n-3 fatty acid ratio in both compartments. Such changes in plasma have been reported to be associated with health benefits through reduced risk for cardiovascular diseases or better protection against degenerative diseases (20, 41) . Additionally, low polyunsaturated fatty acid (PUFA) dietary intake could also be involved in the impairment of muscle performance (3, 54) . Some data suggest that a high n-6/n-3 fatty acid ratio increases the risk of developing poor physical performance (1). These authors suggest that n-3 fatty acids could have a preventive effect on muscle function decline. However, in humans, fish oil extracts (as a source of PUFAs) didn't enhance endurance capacity, although it has been reported Fig. 2 . Effect of 9 wk of DHA supplementation on oxygen consumption by permeabilized myofibers from soleus muscle in the presence (state 3) or absence (state 2) of saturating ADP concentration and with different substrates: glutamate-malate (GM; A), succinate (S; B), or a combination of glutamate-malate and succinate (GMS; C). Mitochondrial coupling efficiency was estimated by the acceptor control ratio (state 3/state 2). Data are means Ϯ SE; n Ն 9; *Different from control, P Ͻ 0.05. Fig. 3 . Effect of 9 wk of DHA supplementation on ADP sensitivity, represented by apparent Km for ADP (app. Km for ADP), of permeabilized myofibers from soleus in the presence of GMS as substrates. The app. Km for ADP was calculated using a nonlinear fitting of the Michaelis-Menten equation. Data are means Ϯ SE; n Ն 8; *Different from control, P Ͻ 0.05. Fig. 4 . Effect of 9 wk of DHA supplementation on calcium retention capacity (CRC) of isolated mitochondria from red vastus muscle. CRC was measured in presence of GM or S and with or without cyclosporin A (CsA), an inhibitor of mitochondrial permeability transition pore. Data are means Ϯ SE; n Ն 8. *Different from control, P Ͻ 0.05. that lipid consumption can increase exercise tolerance in middle-aged mice (29, 50, 64) . However, the underlying mechanisms of such positive effects still remain unclear. In most studies, the DHA source is fish oil. In our study, we used a glycerophospholipid form that has a better bioavailability associated with the fact that our animals were deficient in -3 due to a previous 9-wk low DHA diet to reproduce the low -3 intake in Western diets. Lipid membrane composition is known to change with endurance training that also improves the exercise capacity (27) . Although the mechanism of action is not yet fully understood, some results suggest that a higher DHA content is associated with a reduced perceived exertion and an increase in exercise economy during a steady-state exercise (31) . We report here a situation where DHA supplementation improved the low-intensity exercise capacity as well as cell membrane lipid composition, but without any training. Such an exercise relies mostly on aerobic mitochondrial metabolism. Mitochondrial function measured on permeabilized myofibers appeared to be altered by DHA with a significant increase in state 3 (ADP-stimulated) oxygen consumption from oxidative muscle fibers. The higher oxygen consumption is seen with glutamate-malate as a substrate of complex I. There are no differences with substrate of complex II (succinate) or when succinate is added to glutamate-malate to activate the whole electron transport chain. This would suggest that DHA has a major effect when complex I is involved in phosphorylating conditions. Under nonphosphorylating conditions (substrate alone), the oxygen consumption by permeabilized myofibers was higher with substrates of complex I or complex II, and there was also a tendency when they were used together. This would suggest that DHA has an uncoupling effect on the mitochondria (38) . However, this is rather unlikely in our study because we did not found higher oxygen consumptions in nonphosphorylating conditions on isolated mitochondria, and acceptor control ratio (state 3/state 2 oxygen consumption) was similar in both groups as well. Such a difference can hardly be attributed to the fact that isolated mitochondria were from different muscles than those used to prepare the permeabilized myofibers (due to the larger muscle masses required to prepare isolated mitochondria), as PUFA supplementation usually affects all of the body compartments (58) . We conclude that DHA has a specific effect on the regulation of the respiratory chain. This effect is quite similar to what is usually reported after endurance training (24, 62) . An increase in endurance capacity is not necessarily dependent solely on an increase in the V max of oxygen consumption. In most cases, the change observed at the mitochondrial level after endurance training is a higher V max (due to a higher mitochondrial content in permeabilized myofibers). Here, we could not have this kind of modification in our study since our animals were not trained. However, in endurancetrained animals, other changes at the mitochondrial level can occur, such as alterations in kinetic parameters like a higher apparent K m for ADP. We observed the same result in our study with changes in the affinity of the permeabilized myofibers for ADP, as judged by the significant increase in the apparent K m for ADP. Such an increase would suggest a lower affinity and/or a lower permeability of the mitochondria for ADP (62) . A high apparent K m for ADP as reported in oxidative fibers would correspond to a metabolic mechanism allowing better control of mitochondrial respiration by mitochondrial kinases (65) . Thus, in our study, DHA would affect in a similar way the kinetic parameters of the respiration with a consequence on the mitochondrial function. These changes could contribute to the higher endurance capacity measured with DHA supplementation. This is confirmed by the fact that we report a higher endurance time by DHA-supplemented rats. We also measured the oxygen consumption on isolated muscle mitochondria. Indeed, when isolating mitochondria, it has been suggested that the population of mitochondria collected is mostly from the subsarcolemmal area, but more importantly, with loss of any potential regulatory mechanism. This is rather different with permeabilized myofibers, as they are permeabilized but with limited alteration of their cellular environment (47) . Comparison of the results obtained on these two models may then add information about the importance of the mitochondrial environment on its function. More specifically, because we did not have significant alterations due to DHA on isolated mitochondrial function but major changes on permeabilized myofibers, we can conclude that DHA may exert its effects through the mitochondrial environment. Among hypothetic mechanisms proposed to explain such an importance, components of the cytoskeleton, such as tubulin isoforms, have been suggested to play a role in the regulation of the mitochondrial metabolism (60) . Further experiments are needed to precisely measure that contribution and the potential modulating action of polyunsaturated fatty acids.
The mitochondrial function was not affected only in terms of oxygen consumption. We also report that the calcium-induced PTP opening is occurring earlier with DHA, as indicated by the lower calcium retention capacity of the mitochondria from the DHA group. Inhibition of the PTP opening by the use of CsA, which acts as a regulator of the PTP through inhibition of the activity of cyclophilin D, was also lower with the DHA compared with the control group, with glutamate-malate as a substrate. Although the molecular structure of the PTP is still not fully characterized, its involvement in apoptosis induction has been documented (51) . Recently, a sensitized PTP causing a decrease in the calcium retention capacity has been proposed as an underlying mechanism contributing to the aging-related muscle atrophy (23) . Our results would then suggest that DHA supplementation, instead of preserving mitochondrial function, would be associated with higher apoptosis, contrary to what has been reported in cardiac muscle (45) . In fact, it appears that DHA has either positive or negative action on apoptosis, depending on the type of muscle cell (13, 48) . Moreover, mitochondrial PTP is also considered to be a physiological regulatory tool of the mitochondrial function, besides inducing apoptosis (51) . As pointed out by these authors, in skeletal muscle mitochondria, transient opening of the PTP leads to a decrease in membrane potential, thus acting as a sort of resetting tool without catastrophic and irreversible consequences. Yet further experiments appear to be necessary to determine precisely the exact mechanism of DHA on apoptosis regulation in skeletal muscle. Some authors have reported an association between ROS production and PTP regulation. In our study, we did not find any differences in the mitochondrial release of H 2 O 2 as an indicator of ROS production between the two groups. The absence of oxidative stress is confirmed by the similar values in plasma oxidative stress indices that we determined, including thiol groups, TBARS, or FRAP. Such an alteration is known to be associated with a decrease in ROS production at the mitochondrial level. It would have been interesting to have ROS production at the permeabilized myofiber level. Such measurement is possible on ghost fibers (47) , but due to the limitation in muscle tissue available, this was not done in the present study. The higher sensitivity of the PTP to Ca 2ϩ seen with DHA supplementation would then suggest that DHA could participate in limiting ROS production in adult animals through a higher PTP transient-opening sensitivity, with positive consequences at various levels, including lower lipid and protein oxidation.
It is known that membrane composition can exert a regulatory effect on the mitochondrial electron transport chain (10) . Through its impact on the cell membrane lipid composition found in our study, we can also hypothesize that DHA could act indirectly through changes in the lipid environment of the respiratory complexes. Because we observed a higher mitochondrial oxygen consumption by permeabilized myofibers, we can hypothesize that these changes could be related to consequences of the membrane alterations by the DHA. This is supported by the selective changes that we observed in the activities of complexes of the respiratory chain with higher enzymatic activities of complex III and complex IV. Although we did not analyze mitochondrial membrane composition, it could have been altered by DHA supplementation, as it was in red blood cell and muscle cell membranes with a lower n-6/n-3 ratio. Indeed, membrane composition alterations are usually consistent in all cellular compartments, including cell membrane and mitochondrial membrane (46, 61) .
Another major result in our study is the higher AMPK activation by DHA supplementation, as suggested by the increase in the ratio between both phosphorylated and total AMPK. -3 PUFAs have been shown to activate the AMPK in macrophages as a mediator of their anti-inflammatory properties after 24 h (63). We report here that -3 could also have activating properties on AMPK on a chronic basis. We have evidence that in our study this is associated with a tendency toward a higher phosphorylation level of mTOR, a known putative target of AMPK. Indeed, we studied the acetyl-CoA carboxylase (ACC) enzyme as a target of AMPK. However, although the level of the phosphorylated form of AMPK was significantly higher in DHA group, the levels of ACC phosphorylation were similar in both groups. There are examples in the literature where AMPK phosphorylation level is not always associated with a higher ACC phosphorylation level (25) . Besides, to associate the change in AMPK phosphorylation with some signaling effects, we then used the Ser/Thr phosphorylated antibody instead. This result, together with the higher phosphorylation level of the consensus motif (L/ R)XRXXpS/pT phosphorylated by AMPK, suggests that AMPK has indeed a higher activity as a result of DHA supplementation. Further studies are necessary to precisely determine the consequences of such an activation. It is already known that the association between AMPK and mTOR has a role in the adaptive control of mitochondrial density and protein synthesis following endurance training (49) . These effects of DHA could be mediated by alterations in specific gene expressions. It has been shown that DHA can regulate gene transcription of PPARs (34) . In our study, the increase in the endurance time associated with DHA supplementation could be related to such an action of the DHA at a gene level, as we have reported an increase in the transcription of PPAR␦, which is considered to be a key transcription factor in the regulation of the lipid metabolism and in mitochondrial function (14, 43) .
In conclusion, our study provides strong evidence that DHA supplementation in adult animals induces adaptations that have some similarities with those that are due to endurance training, including increase in endurance time and mitochondrial function of oxidative skeletal muscle fibers. The DHA supplementation could then be considered as an exercise mimic that would have some potential interest in specific populations, such as aging people facing muscle performance decline.
